Inhibition of ASCT2-mediated glutamine uptake blocks prostate cancer growth

Q Wang, RA Hardie, AJ Hoy… - 2nd Prostate Cancer …, 2015 - eprints.qut.edu.au
Inhibition of ASCT2-mediated glutamine uptake blocks prostate cancer growth | QUT ePrints
Queensland University of Technology, Brisbane Australia QUT Home Contact A university for the …

Targeting ASCT2‐mediated glutamine uptake blocks prostate cancer growth and tumour development

Q Wang, RA Hardie, AJ Hoy… - The Journal of …, 2015 - Wiley Online Library
Glutamine is conditionally essential in cancer cells, being utilized as a carbon and nitrogen
source for macromolecule production, as well as for anaplerotic reactions fuelling the …

Regulation of SLC1A4 and SLC1A5 in prostate cancer—response

MA White, DE Frigo - Molecular Cancer Research, 2018 - AACR
In our study, we stated that SLC1A4 was a glutamine transporter. We acknowledge that this
has never been directly shown. To that end, the first articles describing SLC1A4 (ASCT1) …

Glutamine transporters are targets of multiple oncogenic signaling pathways in prostate cancer

MA White, C Lin, K Rajapakshe, J Dong, Y Shi… - Molecular Cancer …, 2017 - AACR
Despite the known importance of androgen receptor (AR) signaling in prostate cancer, the
processes downstream of AR that drive disease development and progression remain …

Alanine-Serine-Cysteine Transporter 2 Inhibition Suppresses Prostate Cancer Cell Growth In Vitro

M Saruta, K Takahara, A Yoshizawa, A Niimi… - Journal of Clinical …, 2022 - mdpi.com
Alanine-serine-cysteine transporter 2 (ASCT2) has been associated with increased levels of
metabolism in various malignant tumors. However, its biological significance in the …

ASCT2: a potential cancer drug target

K Wahi, J Holst - Expert Opinion on Therapeutic Targets, 2019 - Taylor & Francis
Understanding and targeting the metabolic requirements of cancer cells has become a
major focus of cancer researchers and pharmaceutical companies worldwide. There are a …

[HTML][HTML] Targeting glutamine metabolism in prostate cancer

N Bhowmick, E Posadas, L Ellis… - Frontiers in Bioscience …, 2023 - imrpress.com
Glutamine is a conditionally essential amino acid important for cancer cell proliferation
through intermediary metabolism leading to de novo synthesis of purine and pyrimidine …

The role of the glutamine transporter ASCT2 in antineoplastic therapy

E Teixeira, C Silva, F Martel - Cancer chemotherapy and pharmacology, 2021 - Springer
Cancer cells are metabolically reprogrammed to support their high rates of proliferation,
continuous growth, survival, invasion, metastasis, and resistance to cancer treatments …

Antagonizing glutamine bioavailability promotes radiation sensitivity in prostate cancer

M Thiruvalluvan, S Billet, NA Bhowmick - Cancers, 2022 - mdpi.com
Simple Summary Radiation is the standard of care for prostate cancer, but almost half the
patients develop resistant disease. It is imperative to understand the reasons behind …

[HTML][HTML] Glutamine metabolism and prostate cancer

HHH Erb, N Polishchuk, O Stasyk, U Kahya… - Cancers, 2024 - mdpi.com
Simple Summary Glutamine (Gln) plays a critical role in the development and progression of
prostate cancer (PCa). Non-malignant prostate cells are not addicted to Gln, but PCa cells …